LyGenesis' Series A Round

LyGenesis raised a round of funding on May 09, 2018. Investors include Juvenescence.

LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis' lead pre…

Articles about LyGenesis' Series A Round: